Your browser doesn't support javascript.
loading
Late Mortality after Allogeneic Blood or Marrow Transplantation for Inborn Errors of Metabolism: A Report from the Blood or Marrow Transplant Survivor Study-2 (BMTSS-2).
Wadhwa, Aman; Chen, Yanjun; Holmqvist, Anna; Wu, Jessica; Ness, Emily; Parman, Mariel; Kung, Michelle; Hageman, Lindsey; Francisco, Liton; Braunlin, Elizabeth; Miller, Weston; Lund, Troy; Armenian, Saro; Arora, Mukta; Orchard, Paul; Bhatia, Smita.
Afiliação
  • Wadhwa A; Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama.
  • Chen Y; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama.
  • Holmqvist A; Pediatric Oncology and Hematology, Skåne University Hospital, Department of Clinical Sciences, Lund University, Lund, Sweden.
  • Wu J; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama.
  • Ness E; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama.
  • Parman M; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama.
  • Kung M; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama.
  • Hageman L; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama.
  • Francisco L; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama.
  • Braunlin E; Division of Pediatric Cardiology, University of Minnesota, Minneapolis, Minnesota.
  • Miller W; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota; Sangamo Therapeutics, Richmond, California.
  • Lund T; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota.
  • Armenian S; Pediatric Hematology and Oncology, City of Hope, Duarte, California.
  • Arora M; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota.
  • Orchard P; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota.
  • Bhatia S; Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama. Electronic address: sbhatia@peds.uab.edu.
Biol Blood Marrow Transplant ; 25(2): 328-334, 2019 02.
Article em En | MEDLINE | ID: mdl-30292746

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles / 7_ODS3_muertes_prevenibles_nacidos_ninos Base de dados: MEDLINE Assunto principal: Transplante de Medula Óssea / Mucopolissacaridose I / Transplante de Células-Tronco Hematopoéticas / Adrenoleucodistrofia / Leucodistrofia Metacromática Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged / Newborn Idioma: En Revista: Biol Blood Marrow Transplant Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles / 7_ODS3_muertes_prevenibles_nacidos_ninos Base de dados: MEDLINE Assunto principal: Transplante de Medula Óssea / Mucopolissacaridose I / Transplante de Células-Tronco Hematopoéticas / Adrenoleucodistrofia / Leucodistrofia Metacromática Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged / Newborn Idioma: En Revista: Biol Blood Marrow Transplant Ano de publicação: 2019 Tipo de documento: Article